Despite consecutive years of losses, Innoscience’s stock price has surged dramatically—can its market capitalization realistically reach RMB 100 billion?

According to publicly available data: • In December 2024, shortly after its listing, the stock price fluctuated between HK$30.86 and HK$58.25; • In July 2025, the price advanced further, ranging from HK$41.75 to HK$79.20; • In early August 2025, the share price hit a new all-time high of HK$73.55—doubling from its IPO price—and market capitalization surpassed HK$51.5 billion. Notably, between July 3 and August 5, 2025, Innoscience’s stock surged from HK$36.80 to HK$75.15—a rise of over 100%—making it a rare example of a high-growth tech stock in the Hong Kong market. Historically, Hong Kong investors have tended to undervalue hard-tech companies. Innoscience’s decision to list in Hong Kong was, in fact, a pragmatic necessity. This sharp rally was primarily driven by Innoscience’s announcement in August 2025 of a strategic partnership with NVIDIA to jointly promote large-scale adoption of the 800V DC (direct current) power architecture in AI data centers. Compared with the conventional 54V power supply, this new architecture delivers significant improvements in energy efficiency, thermal loss reduction, and system reliability—making it well-suited to meet the projected hundredfold growth in computing power demand. Innoscience stated that its GaN devices possess full-chain capability—from 800V input to output voltages ranging from 15V to 1200V—enabling complete gallium nitride (GaN) power systems capable of meeting the power delivery requirements of megawatt-scale AI computing infrastructure. This move not only elevates Innoscience’s strategic value in data center applications but also signals a pivotal turning point for GaN technology’s large-scale deployment in high-power AI scenarios. Interestingly, on May 21, 2025, after U.S. market hours, Innoscience’s competitor Navitas Semiconductor (NVTS) similarly announced a collaboration with NVIDIA to develop next-generation 800V high-voltage DC (HVDC) architecture—prompting its stock to surge 180%–200%. Reduced losses: Key financial comparisons Milestones in Innoscience’s development. Source: Yufeiyuan Research Institute compilation. Innoscience is a globally leading integrated device manufacturer (IDM) specializing in the research, design, production, and sales of gallium nitride (GaN) power devices. The company successfully listed on the Main Board of the Hong Kong Stock Exchange on December 30, 2024, under stock code 02577.HK. This IPO marked a critical milestone in the company’s development, providing robust capital support for subsequent capacity expansion and R&D investment. Revenue achieves leapfrog growth Innoscience’s revenue performance over recent years reflects strong growth momentum. In 2023, the company achieved revenue of RMB 593 million; in 2024, revenue is expected to increase to approximately RMB 828 million—a year-on-year growth of 39.8%. This growth rate reflects notable success in expanding its market presence in the GaN technology sector, with continued revenue contributions from GaN discrete devices, integrated circuits, wafers, and modules. Year-on-year revenue comparison. Source: Yufeiyuan Research Institute compilation. Profitability: Losses narrowing, gross margin gradually improving Although revenue has grown significantly, profitability remains the core focus of market attention. Innoscience remains in a strategic loss-making phase, as its high-cost structure—centered on market expansion and R&D investment—continues to weigh on profitability.

International investment banks uniformly express optimism about Innoscience.

2. CLSA: Financially, the company has posted losses over the past several years, but with growing market demand and expanded production capacity, it is expected to achieve profitability in 2027. Revenue stood at RMB 593 million in 2023 and is projected to reach RMB 8.01 billion by 2028—a compound annual growth rate (CAGR) of 76%. Gross margin was -61.1% in 2023 and is forecast to improve to 48% by 2028. Operating expense ratios are also expected to decline gradually as economies of scale take effect. The company holds a leading position in the GaN power semiconductor market, and demand for GaN is surging rapidly amid growth in electric vehicles (EVs), AI servers, and renewable energy sectors. CLSA assigns the company an 'Outperform' rating. (Source: Reuters, cn.tradingview.com/news… Date: April 28, 2025) 3. China Merchants Securities: Benefiting from rising GaN application penetration and market expansion, the company’s revenue grew from RMB 68 million in 2021 to RMB 828 million in 2024, and is projected to reach RMB 3.098 billion by 2027—a CAGR of 55.2% between 2024 and 2027. As business scale expands, Innoscience’s gross margin and net profit margin are expected to improve progressively: gross margin is forecast to turn positive in 2025, and net profit margin is expected to turn positive in 2027. Based on a 2030 P/E ratio of 30x (the peer group’s five-year average), with a weighted average cost of capital (WACC) of 12.0% and an RMB/HKD exchange rate of 1.07, the firm assigns an 'Add' rating. (Source: Reuters, cn.tradingview.com/news… Date: April 28, 2025) II. Platinum Tech (300811) Trading rationale: 1. Dongzi Securities: Within the past 10 days, four institutions have issued ratings on this stock—two 'Buy' and two 'Recommend'. The average target price set by institutions over the past 10 days is RMB 52, representing a 30% premium over the current price. According to Dongzi Securities’ big-data analysis, the stock has seen three consecutive days of net inflows from major institutional funds. (Date: April 28, 2025) 2. AVIC Securities: The company’s core business—metal powder core—focuses on the new energy sector. By strategically extending upstream into chip inductors for computing infrastructure, it has established business ties with globally leading GPU chipmakers, further solidifying its industry standing as an 'expert in metallic soft magnetic materials and applications.' A second growth curve has clearly emerged, positioning the company to fully capture the high-growth dividends of the AI era. We project the company’s revenue for 2025–2027 to be RMB 2.08 billion / RMB 2.54 billion / RMB 3.05 billion, representing year-on-year growth of 25.1% / 21.9% / 20.5%, respectively; and net attributable profits of RMB 451 million / RMB 558 million / RMB 684 million, up 20.1% / 23.7% / 22.6% year-on-year, corresponding to P/E ratios of 26x / 21x / 17x.

Innospec Inc. Estimates – NASDAQ:IOSP

Oct 24, 2026

Innospec Inc. financial estimates cover reported data and analyst projections for key financial statements and valuation metrics. The content emphasizes that the information is for reference and does not provide investment advice.

TradingView

2026-04-02

Tudor Investment Corp Lowers Holdings in Innospec Inc.

2026-04-04

Innospec Inc. Reports Q4 2025 Earnings with $455.6M Revenue

2026-04-05

Innospec Schedules First Quarter 2026 Earnings Release and Conference Call

2026-04-07

Barentz Inks Distribution Agreement with Innospec in Canada

2026-04-07

Innospec Schedules First Quarter 2026 Earnings Release and Conference Call